Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Celecoxib versus non-COX-2 selective non-steroidal anti-inflammatory drugs: a review of the clinical effectiveness, safety, and cost effectiveness. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). 2011 Authors' conclusions Evidence from five systematic reviews and one health technology assessment found that celecoxib had similar effects as non-COX-2 selective NSAIDs in pain relief. The results of cost-effectiveness were inconsistent across the identified economic evaluations. Indexing Status Subject indexing assigned by CRD MeSH Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Cost-Benefit Analysiss; Cyclooxygenase 2 Inhibitors; Pain; Pyrazoles; Sulfonamides Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, K1S 5S8 Ottawa, Ontario Canada Email: htainfo@cadth.ca AccessionNumber 32012000038 Date abstract record published 16/06/2012 |